M. Bouchard

Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator.

T. Podor, G. Rivard, M. Pai, 2001, Blood.

Intra‐Arterial Milrinone for Reversible Cerebral Vasoconstriction Syndrome

N. Dupré, S. Verreault, J. Gariépy, 2009, Headache.

Studies of a second family with the Quebec platelet disorder: evidence that the degradation of the alpha-granule membrane and its soluble contents are not secondary to a defect in targeting proteins to alpha-granules.

G. Rivard, C. Hayward, E. Cramer, 1997, Blood.

Fibrinogen degradation products in patients with the Quebec platelet disorder

G. Rivard, C. Hayward, S. Zheng, 1997, British journal of haematology.

The Québec NTBC Study.

John J. Mitchell, F. Alvarez, B. Maranda, 2017, Advances in experimental medicine and biology.